Seeing Is Believing
Currently out of the existing stock ratings of Brooks West, 29 are a BUY (85.29%), 5 are a HOLD (14.71%).
Analyst Brooks West, carries an average stock price target met ratio of 90% that have a potential upside of 22.61% achieved within 385 days. Previously, Brooks West worked at PIPER SANDLER.
Brooks West’s has documented 70 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MDT, Medtronic PLC at 26-Aug-2016.
Analyst best performing recommendations are on EW (EDWARDS LIFESCIENCES CORP).
The best stock recommendation documented was for EW (EDWARDS LIFESCIENCES CORP) at 7/28/2014. The price target of $15.67 was fulfilled within 9 days with a profit of $1.52 (10.74%) receiving and performance score of 11.94.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 17-Dec-2018
$30
$8.93 (42.38%)
$41
4 days ago
(09-Jan-2026)
4/16 (25%)
$8.93 (42.38%)
405
Hold
Since 29-Mar-2023
$21
$-0.07 (-0.33%)
$24
2 months 13 days ago
(31-Oct-2025)
8/8 (100%)
$2.53 (13.70%)
110
Hold
Since 12-Dec-2022
$21
$-0.07 (-0.33%)
$32
2 months 13 days ago
(31-Oct-2025)
7/18 (38.89%)
$2.53 (13.70%)
226
Hold
Since 31-Oct-2025
$22
$0.93 (4.41%)
$42
2 months 13 days ago
(31-Oct-2025)
1/4 (25%)
$3.53 (19.11%)
70
Buy
Since 02-Nov-2023
$31
$9.93 (47.13%)
$42
3 months 6 days ago
(07-Oct-2025)
6/13 (46.15%)
$8.1 (35.37%)
344
What Year was the first public recommendation made by Brooks West?